NFH
JAZZ icon

NEXT Financial Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

NEXT Financial Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$165K Buy
+1,153
New +$150K 0.04% 415

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

NEXT Financial Holdings's JAZZ Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2019: 1,153 shares worth $165K. The stake represents 0.04% of the portfolio and ranks #415 among its holdings.

427 funds tracked by Wall St. Rank hold JAZZ as of Q1 2019.

  • NEXT Financial Holdings held 1,153 shares of Jazz Pharmaceuticals worth $165K as of Q1 2019.
  • Jazz Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
  • Jazz Pharmaceuticals made up 0.04% of NEXT Financial Holdings's portfolio in Q1 2019, its #415 holding.
  • 427 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.